Archaeosomes: an excellent carrier for drug and cell delivery

References

• Alavi SE, Mansouri H, Esfahani MKM, et al. (2014). Archaeosome: as new drug carrier for delivery of paclitaxel to breast cancer. Indian J Clin Biochem 29:150–3
   PubMedGoogle Scholar
• Alving C, Koulchin V, Glenn GM, Rao M. (1995). Liposomes as carriers of peptide antigens: induction of antibodies and cytotoxic T lymphocytes to conjugated and unconjugated peptides. Immunol Rev 145:5–31
   PubMed Web of Science ®Google Scholar
• Bangham A. (1993). Liposomes: the Babraham connection. Chem Phys Lipids, 64:275–85
   PubMed Web of Science ®Google Scholar
• Benvegnu T, Lemiègre L, Cammas-Marion S. (2009). New generation of liposomes called archaeosomes based on natural or synthetic archaeal lipids as innovative formulations for drug delivery. Recent pat Drug Deliv Formul 3:206–20
   PubMedGoogle Scholar
• Benvegnu T, Lemiègre L, Dalençon S, Jeftic J. (2013). Applications of extremophilic archaeal lipids in the field of nanocarriers for oral/topical drug delivery. Curr Biotechnol 2:294–303
   Google Scholar
• Brown DA, Venegas B, Cooke PH, et al. (2009). Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy. Chem Phys Lipids 159:95–103
   PubMed Web of Science ®Google Scholar
• Carrer DC, Higa LH, Tesoriero MVD, et al. (2014). Structural features of ultradeformable archaeosomes for topical delivery of ovalbumin. Colloids Surf B Biointerfaces 121:281–9
   PubMed Web of Science ®Google Scholar
• Chaudhary S, Garg T, Murthy RS, et al. (2014). Recent approaches of lipid-based delivery system for lymphatic targeting via oral route. J Drug Target 10:871–82
   Web of Science ®Google Scholar
• Choquet CG, Patel GB, Beveridge T, Sprott G. (1992). Formation of unilamellar liposomes from total polar lipid extracts of methanogens. Appl Environ Microbiol 58:2894–900
   PubMed Web of Science ®Google Scholar
• Choquet CG, Patel GB, Sprott GD. (1996). Heat sterilization of archaeal liposomes. Can J Microbiol 42:183–6
   Web of Science ®Google Scholar
• Choquet CG, Patel GB, Sprott GD, Beveridge TJ. (1993). Stable liposomes formed from archaeal ether lipids. Advances in bacterial paracrystalline surface layers. Springer US, 252:257–68
   Google Scholar
• Conti S, Polonelli L, Frazzi R, et al. (2000). Controlled delivery of biotechnological products. Curr Pharm Biotechnol 1:313–23
   PubMedGoogle Scholar
• Edgerton M, Levine MJ. (1993). Biocompatibility: its future in prosthodontic research. J Prosth Dent 69:406–15
   PubMed Web of Science ®Google Scholar
• Gagandeep, Garg T, Malik B, et al. (2014). Development and characterization of nano-fiber patch for the treatment of glaucoma. Eur J Pharm Sci 53:10–16
   PubMed Web of Science ®Google Scholar
• Garg T. (2014). Current nanotechnological approaches for an effective delivery of bio-active drug molecules in the treatment of acne. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI: 10.3109/21691401.2014.916715
   Web of Science ®Google Scholar
• Garg T, Goyal AK. (2012). Iontophoresis: drug delivery system by applying an electrical potential across the skin. Drug Deliv Lett 2:270–80
   Google Scholar
• Garg T, Goyal AK. (2014a). Biomaterial-based scaffolds – current status and future directions. Exp Opin Drug Deliv 11:767–89
   PubMed Web of Science ®Google Scholar
• Garg T, Goyal AK. (2014b). Liposomes: targeted and controlled delivery system. Drug Deliv Lett 4:62–71
   Google Scholar
• Garg T, Goyal AK. (2014c). Medicated chewing gum: patient compliance oral drug delivery system. Drug Deliv Lett 4:72–8
   Google Scholar
• Garg T, Goyal AK, Arora S, Murthy R. (2012a). Development, optimization & evaluation of porous chitosan Scaffold formulation of gliclazide for the treatment of type-2 diabetes mellitus. Drug Deliv Lett 2:251–61
   Google Scholar
• Garg T, Kumar A, Rath G, Goyal AK. (2014a). Gastroretentive drug delivery systems for therapeutic management of peptic ulcer. Crit Rev Ther Drug Carrier Syst 31:531–57
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014b). Ancient and advanced approaches for the treatment of an inflammatory autoimmune disease-psoriasis. Crit Rev Ther Drug Carrier Syst 31:331–64
   PubMed Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014c). Biomaterials-based nanofiber scaffold: targeted and controlled carrier for cell and drug delivery. J Drug Target. Early Online, 1–20. DOI: 10.3109/1061186X.2014.992899
   Web of Science ®Google Scholar
• Garg T, Rath G, Goyal AK. (2014d). Comprehensive review on additives of topical dosage forms for drug delivery. Drug Deliv. Early Online, 1–19. DOI: 10.3109/10717544.2013.879355
   PubMed Web of Science ®Google Scholar
• Garg T, Singh O, Arora S, Murthy R. (2011a). Dendrimer—a novel scaffold for drug delivery. Int J Pharm Sci Rev Res 7:211–20
   Google Scholar
• Garg T, Singh O, Arora S, Murthy R. (2011b). Patented microencapsulation techniques and its application. J Pharmacy Res 4:2097–102
   Google Scholar
• Garg T, Singh O, Arora S, Murthy R. (2012b). Scaffold: a novel carrier for cell and drug delivery. Crit Rev Ther Drug Carrier Syst 29:1–63
   PubMed Web of Science ®Google Scholar
• Garg T, Singh S, Goyal AK. (2013). Stimuli-sensitive hydrogels: an excellent carrier for drug and cell delivery. Crit Rev Ther Drug Carrier Syst 30:369–409
   PubMed Web of Science ®Google Scholar
• Gonzalez RO, Higa LH, Cutrullis RA, et al. (2009). Archaeosomes made of Halorubrum tebenquichense total polar lipids: a new source of adjuvancy. BMC Biotechnol 9:71
   PubMed Web of Science ®Google Scholar
• González-Paredes A, Clarés-naveros B, Ruiz-martínez M, et al. (2011). Delivery systems for natural antioxidant compounds: archaeosomes and archaeosomal hydrogels characterization and release study. Int J Pharm 421:321–31
   PubMed Web of Science ®Google Scholar
• González-Paredes A, Manconi M, Caddeo C, et al. (2010). Archaeosomes as carriers for topical delivery of betamethasone dipropionate: in vitro skin permeation study. J Liposome Res 20:269–76
   PubMed Web of Science ®Google Scholar
• Goyal AK, Rath G, Garg T. (2013a). Nanotechnological approaches for genetic immunization. DNA and RNA nanobiotechnologies in medicine: diagnosis and treatment of diseases. Springer Berlin Heidelberg 67–120
   Google Scholar
• Goyal G, Garg T, Malik B, et al. (2013b). Development and characterization of niosomal gel for topical delivery of benzoyl peroxide. Drug Deliv. Early Online, 1–16. doi: 10.3109/10717544.2013.855277
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014a). Current nanotechnological strategies for an effective delivery of drugs in treatment of periodontal disease. Crit Rev Ther Drug Carrier Syst 31:89–119
   PubMed Web of Science ®Google Scholar
• Goyal G, Garg T, Rath G, Goyal AK. (2014b). Current nanotechnological strategies for treating glaucoma. Crit Rev Ther Drug Carrier Syst 31:365–405
   PubMed Web of Science ®Google Scholar
• Gregoriadis G. (1995). Engineering liposomes for drug delivery: progress and problems. Trends Biotechnol 13:527–37
   PubMed Web of Science ®Google Scholar
• Higa LH, Corral RS, Morilla MJ, et al. (2013). Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease. Human Vac Immunother 9:409–12
   PubMed Web of Science ®Google Scholar
• Higa LH, Schilrreff P, Perez AP, et al. (2012). Ultradeformable archaeosomes as new topical adjuvants. Nanomed Nanotechnol Biol Med 8:1319–28
   PubMed Web of Science ®Google Scholar
• Hussain T, Garg T, Goyal AK, Rath G. (2014). Biomedical applications of nanofiber scaffolds in tissue engineering. J Biomater Tissue Eng 4:600–23
   Web of Science ®Google Scholar
• Jain S, Caforio A, Driessen AJ. (2014). Biosynthesis of archaeal membrane ether lipids. Microbial Physiol Metab 5:641–59
   Google Scholar
• Johal HS, Garg T, Rath G, Goyal AK. (2014). Advanced topical drug delivery system for the management of vaginal candidiasis. Drug Deliv. Early Online, 1–14. DOI: 10.3109/10717544.2014.928760
   Web of Science ®Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. (2014a). Advanced drug delivery approaches against periodontitis. Drug Deliv. Early Online, 1–15. DOI: 10.3109/10717544.2014.935531
   Web of Science ®Google Scholar
• Joshi D, Garg T, Goyal AK, Rath G. (2014b). Development and characterization of novel medicated nanofibers against periodontitis. Curr Drug Deliv. Early Online, 1–12. DOI: 10.2174/1567201811666141117144332
   PubMed Web of Science ®Google Scholar
• Kalia V, Garg T, Rath G, Goyal AK. (2014). Development and evaluation of a sublingual film of the antiemetic granisetron hydrochloride. Artif Cells Nanomed Biotechnol. Early Online, 1–5. DOI: 10.3109/21691401.2014.984303
   Web of Science ®Google Scholar
• Kataria K, Sharma A, Garg T, et al. (2014). Novel technology to improve drug loading in polymeric nanofibers. Drug Deliv Lett 4:79–86
   Google Scholar
• Kaur M, Garg T, Narang RK. (2014a). A review of emerging trends in the treatment of tuberculosis. Artif Cells Nanomed Biotechnol. Early Online, 1–7. DOI: 10.3109/21691401.2014.962745
   Web of Science ®Google Scholar
• Kaur M, Garg T, Rath G, Goyal AK. (2014b). Current nanotechnological strategies for effective delivery of bioactive drug molecules in the treatment of tuberculosis. Crit Rev Ther Drug Carrier Syst 31:49–88
   PubMed Web of Science ®Google Scholar
• Kaur M, Malik B, Garg T, et al. (2014c). Development and characterization of guar gum nanoparticles for oral immunization against tuberculosis. Drug Deliv. Early Online, 1–7. DOI: 10.3109/10717544.2014.894594
   Web of Science ®Google Scholar
• Kaur N, Garg T, Goyal AK, Rath G. (2014d). Formulation, optimization and evaluation of curcumin-beta-cyclodextrin-loaded sponge for effective drug delivery in thermal burns chemotherapy. Drug Deliv. Early Online, 1–10. DOI: 10.3109/10717544.2014.963900
   Web of Science ®Google Scholar
• Kaur P, Garg T, Rath G, et al. (2014e). Development, optimization and evaluation of surfactant-based pulmonary nanolipid carrier system of paclitaxel for the management of drug resistance lung cancer using Box–Behnken design. Drug Deliv. Early Online, 1–14. DOI: 10.3109/10717544.2014.993486
   Google Scholar
• Kaur P, Garg T, Rath G, et al. (2014f). Surfactant-based drug delivery systems for treating drug-resistant lung cancer. Drug Deliv. Early Online, 1–12. DOI: 10.3109/10717544.2014.935530
   Web of Science ®Google Scholar
• Kaur P, Garg T, Vaidya B, et al. (2014g). Brain delivery of intranasal in situ gel of nanoparticulated polymeric carriers containing antidepressant drug: behavioral and biochemical assessment. J Drug Target 1–12. DOI: 10.3109/1061186X.2014.994097
   PubMed Web of Science ®Google Scholar
• Kaur R, Garg T, Das Gupta U, et al. (2014h). Preparation and characterization of spray-dried inhalable powders containing nanoaggregates for pulmonary delivery of anti-tubercular drugs. Artif Cells Nanomed Biotechnol. Early Online, 1–6. DOI: 10.3109/21691401.2014.930747
   Web of Science ®Google Scholar
• Kaur R, Garg T, Malik B, et al. (2014i). Development and characterization of spray-dried porous nanoaggregates for pulmonary delivery of anti-tubercular drugs. Drug Deliv. Early Online, 1–6. DOI: 10.3109/10717544.2014.920428
   Web of Science ®Google Scholar
• Kaur R, Garg T, Rath G, Goyal AK. (2014j). Advanced aerosol delivery devices for potential cure of acute and chronic diseases. Crit Rev Ther Drug Carrier Syst 31:495–530
   PubMed Web of Science ®Google Scholar
• Kaur V, Garg T, Rath G, Goyal AK. (2014k). Therapeutic potential of nanocarrier for overcoming to P-glycoprotein. J Drug Target 1–12. DOI: 10.3109/1061186X.2014.947295
   PubMed Web of Science ®Google Scholar
• Kikuchi H, Carlsson A, Yachi K, Hirota S. (1991). Possibility of heat sterilization of liposomes. Chem Pharm Bull 39:1018–22
   PubMed Web of Science ®Google Scholar
• Kirilenko V, Gregoriadis G. (1993). Fat soluble vitamins in liposomes: studies on incorporation efficiency and bile salt induced vesicle disintegration. J Drug Target 1:361–8
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dennis Sprott G. (2003). Archaeosomes as self-adjuvanting delivery systems for cancer vaccines. J Drug Target 11:515–24
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dicaire CJ, Patel GB, Sprott GD. (2000). Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect Immun 68:54–63
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sad S, Patel GB, Sprott GD. (2003). Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge. Cancer Res 63:2526–34
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sprott GD. (2007). Archaeosome vaccine adjuvants for cross-priming CD8 + T cell immunity. Vaccine adjuvants and delivery systems. Wiley Online Library 263–94
   Google Scholar
• Li Z, Chen J, Sun W, Xu Y. (2010). Investigation of archaeosomes as carriers for oral delivery of peptides. Biochem Biophys Res Commun 394:412–17
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang L, Sun W, et al. (2011). Archaeosomes with encapsulated antigens for oral vaccine delivery. Vaccine 29:5260–6
   PubMed Web of Science ®Google Scholar
• Malik R, Garg T, Goyal AK, Rath G. (2014). Polymeric nanofibers: targeted gastro-retentive drug delivery systems. J Drug Target 1–16. DOI: 10.3109/1061186X.2014.965715
   Web of Science ®Google Scholar
• Marwah H, Garg T, Goyal AK, Rath G. (2014). Permeation enhancer strategies in transdermal drug delivery. Drug Deliv. Early Online, 1–15. DOI: 10.3109/10717544.2014.935532
   Web of Science ®Google Scholar
• Modgill V, Garg T, Goyal AK, Rath G. (2014a). Permeability study of ciprofloxacin from ultra-thin nanofibrous film through various mucosal membranes. Artif Cells Nanomed Biotechnol. Early Online, 1–6. DOI: 10.3109/21691401.2014.924007
   Web of Science ®Google Scholar
• Modgill V, Garg T, Goyal AK, Rath G. (2014b). Transmucosal delivery of linagliptin for the treatment of type-2 diabetes mellitus by ultra-thin nanofibers. Curr Drug Deliv. Early Online, 1–10. doi: 10.2174/1567201811666141117144332
   PubMed Web of Science ®Google Scholar
• Morie A, Garg T, Goyal AK, Rath G. (2014). Nanofibers as novel drug carrier – an overview. Artif Cells Nanomed Biotechnol 1–9
   PubMed Web of Science ®Google Scholar
• Napotnik T, Valant J, Gmajner D, et al. (2013). Cytotoxicity and uptake of archaeosomes prepared from Aeropyrum pernix lipids. Human Exp Toxicol 32:950–9
   PubMed Web of Science ®Google Scholar
• Pabreja S, Garg T, Rath G, Goyal AK. (2014). Mucosal vaccination against tuberculosis using Ag85A-loaded immunostimulating complexes. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI: 10.3109/21691401.2014.966195
   Web of Science ®Google Scholar
• Patel GB, Chen W. (2005). Archaeosome immunostimulatory vaccine delivery system. Curr Drug Deliv 2:407–21
   PubMedGoogle Scholar
• Patel GB, Chen W. (2006). Archaeosomes as drug and vaccine nanodelivery systems. Nanocarrier technologies. Springer Netherlands, 17–40
   Google Scholar
• Patel GB, Omri A, Deschatelets L, Dennis Sprott G. (2002). Safety of archaeosome adjuvants evaluated in a mouse model 1. J Liposome Res 12:353–72
   PubMed Web of Science ®Google Scholar
• Patel GB, Sprott GD. (1999). Archaeobacterial ether lipid liposomes (archaeosomes) as novel vaccine and drug delivery systems. Crit Rev Biotechnol 19:317–57
   PubMed Web of Science ®Google Scholar
• Perrie Y, Kirby D, Bramwell VW, Mohammed AR. (2007). Recent developments in particulate-based vaccines. Recent Pat Drug Deliv Formul 1:117–29
   PubMedGoogle Scholar
• Relini A, Cassinadri D, Fan Q, et al. (1996). Effect of physical constraints on the mechanisms of membrane fusion: bolaform lipid vesicles as model systems. Biophys J 71:1789–95
   PubMed Web of Science ®Google Scholar
• Ren X, Liu K, Zhang Q, et al. (2014). Design, fabrication, and characterization of archaeal tetraether free-standing planar membranes in a PDMS- and PCB-based fluidic platform. ACS Appl Mater Interfaces 6:12618–28
   PubMed Web of Science ®Google Scholar
• Réthoré G, Montier T, Le Gall T, et al. (2007). Archaeosomes based on synthetic tetraether-like lipids as novel versatile gene delivery systems. Chem Commun 20:2054–6
   PubMed Web of Science ®Google Scholar
• Rohilla R, Garg T, Bariwal J, et al. (2014a). Development, optimization and characterization of glycyrrhetinic acid–chitosan nanoparticles of atorvastatin for liver targeting. Drug Deliv. Early Online, 1–8. DOI: 10.3109/10717544.2014.977460
   Web of Science ®Google Scholar
• Rohilla R, Garg T, Goyal AK, Rath G. (2014b). Herbal and polymeric approaches for liver-targeting drug delivery: novel strategies and their significance. Drug Deliv. Early Online, 1–17. DOI: 10.3109/10717544.2014.945018
   Web of Science ®Google Scholar
• Sharma A, Garg T, Aman A, et al. (2014a). Nanogel – an advanced drug delivery tool: current and future. Artif Cells Nanomed Biotechnol. Early Online, 1–13. DOI: 10.3109/21691401.2014.930745
   Web of Science ®Google Scholar
• Sharma R, Garg T, Goyal AK, Rath G. (2014b). Development, optimization and evaluation of polymeric electrospun nanofiber: a tool for local delivery of fluconazole for management of vaginal candidiasis. Artif Cells Nanomed Biotechnol. Early Online, 1–8. DOI: 10.3109/21691401.2014.966194
   Web of Science ®Google Scholar
• Sharma R, Singh H, Joshi M, et al. (2014c). Recent advances in polymeric electrospun nanofibers for drug delivery. Crit Rev Ther Drug Carrier Syst 31:187–217
   PubMed Web of Science ®Google Scholar
• Singh B, Garg T, Goyal AK, Rath G. (2014a). Recent advancements in the cardiovascular drug carriers. Artif Cells Nanomed Biotechnol 1–10
   Web of Science ®Google Scholar
• Singh H, Sharma R, Joshi M, et al. (2014b). Transmucosal delivery of Docetaxel by mucoadhesive polymeric nanofibers. Artif Cells Nanomed Biotechnol. Early Online, 1–10. doi: 10.3109/21691401.2014.885442
   Web of Science ®Google Scholar
• Singh K, Arora N, Garg T. (2012a). RFID: a trustable security tool in pharmaceutical industry. Am J Pharm Tech Res 2:113–27
   Google Scholar
• Singh K, Arora N, Garg T. (2012b). Superbug: antimicrobial resistance due to NDM-1. Int J Inst Pharmacy Life Sci 2:58–66
   Google Scholar
• Singh O, Garg T, Rath G, Goyal AK. (2014c). Microbicides for the treatment of sexually transmitted HIV infections. J Pharm 1–18. DOI: org/10.1155/2014/352425
   Google Scholar
• Sprott GD, Tolson DL, Patel GB. (1997). Archaeosomes as novel antigen delivery systems 1. FEMS Microbiol Lett 154:17–22
   PubMed Web of Science ®Google Scholar
• Szoka FJr, Papahadjopoulos D. (1980). Comparative properties and methods of preparation of lipid vesicles (liposomes). Annu Rev Biophys Bioeng 9:467–508
   PubMedGoogle Scholar
• Vossenberg JL, Ubbink-Kok T, Elferink MG, et al. (1995). Ion permeability of the cytoplasmic membrane limits the maximum growth temperature of bacteria and archaea. Mol Microbiol 18:925–932
   PubMed Web of Science ®Google Scholar
• Whitcomb DC, Lowe ME. (2007). Human pancreatic digestive enzymes. Digest Dis Sci 52:1–17
   PubMed Web of Science ®Google Scholar
• Woodle MC, Lasic DD. (1992). Sterically stabilized liposomes. Biochim Biophys Acta Rev Biomembr 1113:171–99
   PubMed Web of Science ®Google Scholar
• Yamauchi K, Doi K, Kinoshita M, et al. (1992). Archaebacterial lipid models: highly salt-tolerant membranes from 1,2-diphytanylglycero-3-phosphocholine. Biochim Biophys Acta Biomembr 1110:171–7
   PubMed Web of Science ®Google Scholar
• Zavec AB, Ota A, Zupancic T, et al. (2014). Archaeosomes can efficiently deliver different types of cargo into epithelial cells grown in vitro. J Biotechnol 192 A:130–5
   Web of Science ®Google Scholar
• Zuidam NJ, Lee SS, Crommelin DJ. (1993). Sterilization of liposomes by heat treatment. Pharm Res, 10:1591–6
   PubMed Web of Science ®Google Scholar